7-Chloro-5-methyl-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidine, 95.0%, 5g

5-(4-ethylbenzyl)-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

9,10-Dibromoanthracene>98.0%(GC)100g

Fmoc-Val-Cit-PAB-OH>98.0%(HPLC)100mg

[3-(3-Amino-phenyl)-5-trifluoromethyl-pyridin-2-yl]-dimethyl-amine, 95.0%, 1g

7-Methoxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one, 95%, 50mg

{2-[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethoxy]ethoxy}acetic acid, 99.0%, 100mg

4-Chloro-6-pyrrolidin-1-yl-pyrimidin-5-ylamine, 95.0%, 100mg

Ethyl 8-cyano-3-iodoimidazo[1,2-a]pyridine-2-carboxylate, 250mg

1-Bromo-2-methylnaphthalene, 90.0%, 5g

boc-E-acp-oh, 98.00%, 1g

ethyl 4-(3-methoxyphenyl)-2,4-dioxobutanoate, 95.0%, 10g

Chrysoidin R (CI 11320), pure, 50 g, glass packaging